Blog

Disruption

 August 27, 2018

In the News: August 23–30

By

This week: Disrupters top list of health care’s most influential people; new cervical cancer screening recommendations give women more screening options; and the level of exposure to out-of-network claims for...

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 December 18, 2017

In the News: December 14–21

By

This week: Tax reform bill passes House and Senate, gene therapy for hemophilia, a nationally backed continuum of care for mental health and the repeal of net neutrality

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 October 6, 2017

Precision Medicine: Hits and Misses

By

Precision medicine is so broad, you need to focus your investment. This post describes the 3 main activities—screening, diagnostics and therapeutics—associated with precision medicine and outlines which service lines are being...

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 February 28, 2017

Navigating Virtual Health Reimbursement 101

By

Navigating virtual health reimbursement can be difficult. Reimbursement varies depending on the payer, state, practicing clinician, geographical location and more. As virtual health policies are undergoing constant change, health systems...

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
 September 28, 2016

In the News: September 22-28, 2016

By

Sg2 is dedicated to helping our clients interpret the latest news and trends in health care. Below you’ll find our analysis of this week’s key industry headlines, along with links...

  • Follow Sg2 on Facebook
  • Follow Sg2 on Twitter
  • Connect with Sg2 on LinkedIn
  • Share
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube